BioLife Solutions Current Ratio 2010-2025 | BLFS
BioLife Solutions current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| BioLife Solutions Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $0.13B | $0.03B | 4.73 |
| 2024-12-31 | $0.15B | $0.03B | 4.55 |
| 2024-09-30 | $0.09B | $0.03B | 2.78 |
| 2024-06-30 | $0.09B | $0.03B | 2.86 |
| 2024-03-31 | $0.11B | $0.04B | 2.89 |
| 2023-12-31 | $0.12B | $0.04B | 2.86 |
| 2023-09-30 | $0.12B | $0.04B | 2.74 |
| 2023-06-30 | $0.12B | $0.04B | 3.04 |
| 2023-03-31 | $0.13B | $0.05B | 2.81 |
| 2022-12-31 | $0.14B | $0.05B | 3.11 |
| 2022-09-30 | $0.14B | $0.04B | 3.68 |
| 2022-06-30 | $0.12B | $0.03B | 3.55 |
| 2022-03-31 | $0.12B | $0.04B | 3.39 |
| 2021-12-31 | $0.13B | $0.04B | 2.95 |
| 2021-09-30 | $0.13B | $0.04B | 3.65 |
| 2021-06-30 | $0.13B | $0.03B | 4.07 |
| 2021-03-31 | $0.12B | $0.02B | 7.12 |
| 2020-12-31 | $0.12B | $0.02B | 7.37 |
| 2020-09-30 | $0.13B | $0.01B | 15.28 |
| 2020-06-30 | $0.05B | $0.01B | 6.18 |
| 2020-03-31 | $0.03B | $0.03B | 1.04 |
| 2019-12-31 | $0.02B | $0.01B | 3.14 |
| 2019-09-30 | $0.03B | $0.01B | 6.49 |
| 2019-06-30 | $0.03B | $0.00B | 9.42 |
| 2019-03-31 | $0.04B | $0.00B | 14.50 |
| 2018-12-31 | $0.04B | $0.00B | 19.37 |
| 2018-09-30 | $0.04B | $0.00B | 18.27 |
| 2018-06-30 | $0.02B | $0.00B | 11.31 |
| 2018-03-31 | $0.01B | $0.00B | 7.81 |
| 2017-12-31 | $0.01B | $0.00B | 6.56 |
| 2017-09-30 | $0.01B | $0.00B | 5.85 |
| 2017-06-30 | $0.01B | $0.00B | 5.43 |
| 2017-03-31 | $0.01B | $0.00B | 5.14 |
| 2016-12-31 | $0.01B | $0.00B | 4.08 |
| 2016-09-30 | $0.01B | $0.00B | 1.43 |
| 2016-06-30 | $0.01B | $0.00B | 2.17 |
| 2016-03-31 | $0.01B | $0.00B | 3.59 |
| 2015-12-31 | $0.01B | $0.00B | 4.04 |
| 2015-09-30 | $0.01B | $0.00B | 5.08 |
| 2015-06-30 | $0.01B | $0.00B | 8.01 |
| 2015-03-31 | $0.01B | $0.00B | 7.49 |
| 2014-12-31 | $0.01B | $0.00B | 9.64 |
| 2014-09-30 | $0.01B | $0.00B | 15.41 |
| 2014-06-30 | $0.01B | $0.00B | 21.98 |
| 2014-03-31 | $0.02B | $0.00B | 13.79 |
| 2013-12-31 | $0.00B | $0.00B | 1.15 |
| 2013-09-30 | $0.00B | $0.00B | 1.35 |
| 2013-06-30 | $0.00B | $0.00B | 1.28 |
| 2013-03-31 | $0.00B | $0.00B | 1.30 |
| 2012-12-31 | $0.00B | $0.00B | 1.19 |
| 2012-09-30 | $0.00B | $0.00B | 1.21 |
| 2012-06-30 | $0.00B | $0.00B | 1.48 |
| 2012-03-31 | $0.00B | $0.00B | 2.00 |
| 2011-12-31 | $0.00B | $0.00B | 2.00 |
| 2011-09-30 | $0.00B | $0.00B | 2.02 |
| 2011-06-30 | $0.00B | $0.00B | 2.00 |
| 2011-03-31 | $0.00B | $0.00B | 1.98 |
| 2010-12-31 | $0.00B | $0.00B | 2.39 |
| 2010-09-30 | $0.00B | $0.01B | 0.09 |
| 2010-06-30 | $0.00B | $0.01B | 0.10 |
| 2010-03-31 | $0.00B | $0.01B | 0.09 |
| 2009-12-31 | $0.00B | $0.00B | 2.50 |
| 2009-09-30 | $0.00B | $0.01B | 0.10 |
| 2009-06-30 | $0.00B | $0.01B | 0.09 |
| 2009-03-31 | $0.00B | $0.01B | 0.17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.008B | $0.082B |
| BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.381B | 27.82 |
| Boston Scientific (BSX) | United States | $149.868B | 37.52 |
| Stryker (SYK) | United States | $143.347B | 29.97 |
| EssilorLuxottica (ESLOY) | France | $128.152B | 0.00 |
| Medtronic (MDT) | Ireland | $110.735B | 15.70 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.273B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.835B | 26.69 |
| ResMed (RMD) | United States | $37.196B | 27.94 |
| Agilent Technologies (A) | United States | $32.827B | 21.40 |
| GE HealthCare Technologies (GEHC) | United States | $32.638B | 15.50 |
| Terumo (TRUMY) | Japan | $26.398B | 34.29 |
| Koninklijke Philips (PHG) | Netherlands | $21.463B | 15.06 |
| Insulet (PODD) | United States | $21.334B | 83.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.048B | 11.59 |
| Baxter (BAX) | United States | $15.390B | 11.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.627B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.442B | 22.42 |
| Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
| Prestige Consumer Healthcare (PBH) | United States | $4.123B | 18.42 |
| Perrigo (PRGO) | Ireland | $3.643B | 9.23 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.415B | 15.55 |
| Envista Holdings (NVST) | United States | $3.202B | 26.61 |
| ICU Medical (ICUI) | United States | $3.144B | 23.18 |
| QuidelOrtho (QDEL) | United States | $1.896B | 13.04 |
| LeMaitre Vascular (LMAT) | United States | $1.848B | 41.30 |
| AtriCure (ATRC) | United States | $1.554B | 0.00 |
| Acuren (TIC) | United States | $1.324B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.132B | 11.49 |
| Neogen (NEOG) | United States | $1.072B | 13.72 |
| Green Thumb Industries (GTBIF) | United States | $1.042B | 23.43 |
| Phibro Animal Health (PAHC) | United States | $0.968B | 12.37 |
| InMode (INMD) | Israel | $0.839B | 8.46 |
| Kestra Medical Technologies (KMTS) | United States | $0.772B | 0.00 |
| CeriBell (CBLL) | United States | $0.647B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Owens & Minor (OMI) | United States | $0.567B | 4.71 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.525B | 0.00 |
| Valneva SE (VALN) | France | $0.478B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.377B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.362B | 0.00 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.319B | 11.74 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.288B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.262B | 22.07 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| ZimVie (ZIMV) | United States | $0.245B | 11.13 |
| Sanara MedTech (SMTI) | United States | $0.242B | 0.00 |
| Quanterix (QTRX) | United States | $0.238B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.229B | 68.00 |
| Canopy Growth (CGC) | Canada | $0.228B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Biote (BTMD) | United States | $0.217B | 6.09 |
| Cresco Labs (CRLBF) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.206B | 54.55 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.19 |
| Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
| Organigram Global (OGI) | Canada | $0.173B | 0.00 |
| Exagen (XGN) | United States | $0.154B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 15.40 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Veru (VERU) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.34 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| MacroGenics (MGNX) | United States | $0.083B | 0.00 |
| Agape ATP (ATPC) | $0.079B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Apyx Medical (APYX) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| ImmuCell (ICCC) | United States | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Nephros (NEPH) | United States | $0.053B | 71.43 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 12.98 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |